In this article
If you've ever held a peptide vial under the bench lamp and wondered why the molecule inside is built from twenty specific amino acids out of hundreds that exist, a new preprint from bioRxiv offers a small but real clue. The paper asks a basic question: could ancient, shorter amino acids have done the folding job before today's standard ones took over? The answer, from a team that combined computer design, crystal structures, and molecular dynamics simulations, points to ornithine and 2,4-diaminobutyric acid as plausible stand-ins for lysine and arginine on early Earth.
Why these two short amino acids matter to origins-of-life research
Proteins are chains of amino acids. Each amino acid has a side chain, which is the little chemical group that hangs off the backbone and gives the chain its character. Lysine and arginine have long, positively charged side chains (cationic means positively charged). On modern Earth, lysine and arginine are everywhere. On the early Earth, the evidence suggests they were scarce. Shorter cationic amino acids, ornithine and 2,4-diaminobutyric acid (often shortened to Dab), were likely easier to make from simple chemistry. So the puzzle is: if ancient proteins had to fold into stable shapes, and the long cationic amino acids were missing, what held the structure together?
The researchers designed new sequences using computer tools, built the peptides, and tested whether they would fold into a specific ancient shape called the double-Ψ beta-barrel, or DPBB. A beta-barrel is a protein shape where the backbone folds back and forth like a sheet of paper that rolls into a tube. The double-Ψ version is one of the oldest known barrel shapes, and it shows up in many modern enzymes.

What they actually did at the bench
The team wrote software to design sequences built from a "prebiotic" amino acid set, meaning the amino acids thought to be available before life existed. They swapped in ornithine and Dab where modern proteins would normally use lysine and arginine. Then they synthesized the peptides and ran the standard biophysics toolkit: circular dichroism to check secondary structure (the local twists and sheets in the chain), thermal melts to see how stable the fold is when heated, and X-ray crystallography to capture the actual 3D shape. Molecular dynamics simulations let them watch the peptide flex and settle on a computer.
Under normal dilute aqueous conditions (think a typical bench concentration, a few micromolar in a standard buffer), none of the designed sequences folded. That's a fair result. Prebiotic Earth wasn't dilute. The team pushed the concentration up to high levels, the kind you might get in a drying tide pool or a warm little pond, and one ornithine-containing variant folded. The Dab version folded too. The crystal structures showed something the authors didn't quite expect: the peptides adopted a closely related fold called the double-Ζ beta-barrel (DZBB), which the authors describe as a likely evolutionary stepping stone between older and newer barrel shapes.

What this means for how you handle peptides at the bench
This is origins-of-life science, not a recipe change for reconstitution. Still, the work carries a practical reminder for anyone who handles peptide vials. The foldability of a peptide depends on more than just the twenty standard amino acids. Side-chain length, charge, and how crowded the solution is all matter. Ornithine and Dab are one carbon shorter than lysine and arginine, respectively. If you ever see a custom peptide ordered with ornithine in place of lysine, expect slightly different behavior in solution: a tighter fold at high concentration, possibly a different melting point, and a different pH sensitivity around the side chain's pKa (the pH at which the charge flips on or off).
For storage, the lesson is the usual one, but worth repeating because the community keeps losing vials to it. Keep lyophilized peptide cold and dry, typically at -20°C in a sealed vial with a desiccant. Once reconstituted, treat the solution as the fragile thing it is: cold storage (4°C for short-term use, -20°C for longer), sterile technique, and accurate dilution math so you don't push concentration into ranges where aggregation or hydrolysis starts to compete with your assay. A 3 mL glass cartridge paired with a reusable metal pen and a quality bacteriostatic water diluent gives you repeatable draws without repeated punctures of the stock vial, which protects both purity and the peptide from repeated freeze-thaw stress. The ancient amino acids in this study folded only when the solution got concentrated. Your modern peptide is doing the opposite job in the vial: it needs to stay dissolved, dilute enough, and cold enough to keep its intended fold intact until you're ready to use it.
Frequently asked questions
What is the double-psi beta-barrel?
It is one of the oldest known protein shapes, a beta-sheet that rolls into a barrel and shows up in many modern enzymes. The study used it as a test case for ancient amino acids.
Why are ornithine and Dab interesting for early Earth chemistry?
They are shorter, positively charged amino acids that were likely easier to form on the prebiotic Earth than lysine or arginine, so they could have stood in before the modern genetic code locked in.
Should I store or reconstitute peptides differently because of this study?
No direct change. The takeaway is that side-chain length and solution concentration affect folding, so keep lyophilized peptide cold and dry and reconstituted solutions cold, sterile, and accurately diluted.
Prompted by this coverage at bioRxiv →
Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators
Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
What the research community gets wrong about ancient amino acids (ornithine and Dab)
Ornithine and 2,4-diaminobutyric acid (Dab) show up more often in custom peptides than most benches expect, and a few habits cause avoidable trouble at the vial. Here is what tends to trip people up.
- Treating ornithine like a drop-in copy of lysine. Ornithine is one carbon shorter than lysine, and Dab is one carbon shorter than arginine. That shorter side chain shifts the pKa (the pH where the charge switches on or off), so the same buffer can leave the side chain in a different charge state. Expect solution behavior to differ, not match.
- Reading a peptide that will not fold as a failed synthesis. In the study behind this article, the designed sequences stayed unfolded at ordinary dilute bench concentrations and only folded when the solution was pushed to very high concentration. Concentration is a variable you set, not a pass or fail grade on the peptide.
- Assuming ornithine is as shelf-stable as the standard amino acids. A free ornithine or Dab side-chain amine is reactive and can slowly cyclize or react over time, especially in warm or wet conditions. Cold, dry, sealed storage matters more here, not less.
- Mixing up the barrel shapes. The double-psi beta-barrel (DPBB) and the double-zeta beta-barrel (DZBB) are related but not the same fold. The crystal structures in this work landed on the DZBB, so do not assume a substituted peptide reproduces the exact fold you were aiming for.
- Thinking "prebiotic" means it has nothing to do with modern bench work. The general lesson (side-chain length, charge, and crowding all change how a chain settles in solution) applies to any peptide you reconstitute, not just ancient ones.
From our bench: If you have run a side-by-side on an ornithine- or Dab-substituted peptide against its lysine or arginine version, we want your numbers. Tell us the buffer, the concentration, and what you measured (a circular dichroism trace, a thermal melt temperature, or just how cleanly it went back into solution after reconstitution). Real observations from your bench, with no rounding to make them look tidy, help the next person set expectations before they open a vial.
Sources
- Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
- Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
- Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
- PubChem: L-Ornithine (CID 6262)
- PubChem: 2,4-Diaminobutyric acid (CID 470)
- PubChem: L-Arginine (CID 6322)
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.